Medicare Enrolled

Dr. Maria Dungo, M.D.

Hematology & Oncology · Los Alamitos, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
3801 KATELLA AVE STE 207, Los Alamitos, CA 90720
5625989745
In practice since 2006 (20 years)
NPI: 1235101874 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dungo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dungo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dungo

Dr. Maria Dungo is a hematology & oncology specialist in Los Alamitos, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dungo performed 15,315 Medicare services across 855 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dungo received a total of $8,292 from 31 pharmaceutical and/or device companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dungo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 26% volume in CA $8,292 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,315
Medicare services
Top 26% in CA for hematology & oncology
855
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~766 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, heparin sodium, (heparin lock flush), per 10 units 7,208 $0 $0
Denosumab injection (Prolia/Xgeva) 6,120 $18 $39
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
435 $7 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
366 $91 $242
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
234 $12 $36
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
181 $17 $52
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
171 $8 $9
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
110 $1 $1
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
102 $138 $316
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
97 $117 $322
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
84 $1 $3
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
83 $100 $222
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $50 $203
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
46 $68 $156
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $143 $370
New patient office visit, complex (60-74 min) 11 $169 $451
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
89.1% medium
9.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,292
Total received (2018-2024)
Avg $1,185/year across 7 years
Top 35% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
169
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,288 (63.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,847 (34.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$157 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24
2023
$5,207
2022
$126
2021
$270
2020
$67
2019
$1,114
2018
$1,484

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$24
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$5,226
Amgen Inc.
$382
Pharmacyclics LLC, An AbbVie Company
$328
Novartis Pharmaceuticals Corporation
$264
Astellas Pharma US Inc
$230
E.R. Squibb & Sons, L.L.C.
$212
Janssen Pharmaceuticals, Inc
$192
Incyte Corporation
$191
Merck Sharp & Dohme Corporation
$179
Lilly USA, LLC
$151
PFIZER INC.
$151
COMSORT, Inc
$100
Celgene Corporation
$80
AstraZeneca Pharmaceuticals LP
$70
Takeda Pharmaceuticals U.S.A., Inc.
$64
EMD Serono, Inc.
$61
Seagen Inc.
$49
Puma Biotechnology, Inc.
$45
Genentech USA, Inc.
$36
Alexion Pharmaceuticals, Inc.
$36
INSYS Therapeutics Inc
$29
Myovant Sciences Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$27
Seattle Genetics, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$22
Janssen Biotech, Inc.
$22
Exelixis Inc.
$22
Sirtex Medical Inc
$22
TerSera Therapeutics LLC
$19
GENZYME CORPORATION
$18
Dova Pharmaceuticals
$11
Top 3 companies account for 71.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Abraxane · Aliqopa · Aranesp · Avastin · BAVENCIO · BOSULIF · BRAFTOVI · Bavencio · Cabometyx · DARZALEX · Doptelet · EMEND · EMPLICITI · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · MEKINIST · MONJUVI · MVASI · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OPDIVO · ORGOVYX · PROMACTA · Padcev · Pomalyst · Prolia · RYDAPT · SIR-Spheres Microspheres · SUTENT · SYNDROS · TASIGNA · TECENTRIQ · Trodelvy · ULTOMIRIS · VERZENIO · XARELTO · XTANDI · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a hematology & oncology specialist in Los Alamitos?
Compare hematology & oncology specialists in the Los Alamitos area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
309
Per 100K population
9.8
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dungo is a mixed practice specialist, with above-average Medicare volume (top 26% in CA), with consulting-driven industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dungo experienced with injection, heparin sodium, (heparin lock flush), per 10 units?
Based on Medicare claims data, Dr. Dungo performed 7,208 injection, heparin sodium, (heparin lock flush), per 10 units services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dungo receive payments from pharmaceutical companies?
Yes. Dr. Dungo received a total of $8,292 from 31 companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dungo's costs compare to other hematology & oncology specialists in Los Alamitos?
Dr. Dungo's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dungo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →